Stock screener

ACRS

Conviction 100HealthcareScan · Thu, Jun 25, 2026
Bullish harami
ACRS$4.92+2.61%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 1.73M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Aclaris Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.aclaristx.com
Price4.92
Change+2.61%
Gap+0.42%
Rel volume2.88×
Avg volume1.62M
Avg $ vol7.37M
SMA 204.51
SMA 504.51
SMA 2003.30
Price vs 50+9.03%
Price vs 200+49.06%
MA stackbullish
50/200 cross
Supertrenddown · 4.99
RSI (14)61
MACD hist0.06
MACD crossbull · 3d
Stoch %K / %D81 / 77
ADX (14)17
+DI / −DI24 / 12
RSI divergence
MACD divergence
ATR %+5.33%
ADR %5.83%
52w high5.09
52w low1.41
From 52w high-3.44%
Above 52w low+248.58%
New 52w highNo
SqueezeOff
Bollinger width19.73%
%B0.96
Donchian pos80.78%
Donchian high5.12
Donchian low4.07
AVWAP (52w high)4.57
vs AVWAP high+7.65%
AVWAP (52w low)3.23
vs AVWAP low+52.22%
OBV trendUp
Chaikin MF (20)-0.07
Today vs 20d2.88×
Avg vol (14d)1.73M
Avg vol (20d)1.62M
Avg $ vol (20d)7.37M
Market cap686.45M
RS 3m (vs SPY)+32.89%
RS 6m (vs SPY)+44.81%
RS line new highNo
Trend template8/8
Technical rank89.5
1 week+11.20%
1 month+8.98%
3 months+36.91%
6 months+60.10%
1 year+223.36%
YTD+70.66%
P/E-10.57
P/B4.78
P/S87.71
P/FCF-14.54
EPS-0.5300
Div yield
ROE-45.20%
ROA-32.67%
Debt/Eq0.07
Current4.03
EV/EBITDA-8.81
Gross margin41.41%
Net margin-829.58%
Rev growth-58.19%
EPS growth50.84%
Price target10.67
Target upside117.09%
Analyst ratingBuy
Institutional85.18%
Ent. value668.52M
Revenue2M
Net income-19.82M
Gross profit435K
Free cash flow-47.22M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out139.66M
Employees73
ListedWed, Oct 7, 2015
Free float98.38M
Float %81.6%
Short interest8.08M
Days to cover8.8d
Short volume62.5%
Squeeze score71 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.16 · 6 est
Last EPS vs est−$0.15 vs −$0.16
Last surprise+6.3% beat
Setup gradeA+
Conviction100 / 100
Pattern quality
Tech rank89.5 / 100
Group rank50 / 100
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmBullish harami
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ACRS

All disclosures →
No recent disclosed trades by Congress in ACRS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ACRS · 6 buys · 4 sells

InsiderSideShares
Molineaux Christopher P.
Director · Common Stock · 2026-06-05
Exercise11.58K
Humphries William D.
Director · Common Stock · 2026-06-05
Exercise11.58K
MILANO VINCENT
Director · Restricted Stock Units · 2026-06-05
Exercise11.58K
SCHIFF ANDREW N
Director · Common Stock · 2026-06-05
Exercise11.58K
GOWEN MAXINE
Director · Common Stock · 2026-06-05
Exercise11.58K
GOWEN MAXINE
Director · Restricted Stock Units · 2026-06-05
Exercise11.58K
MILANO VINCENT
Director · Common Stock · 2026-06-05
Exercise11.58K
Mehra Anand
Director · Common Stock · 2026-06-05
Exercise11.58K
SCHIFF ANDREW N
Director · Restricted Stock Units · 2026-06-05
Exercise11.58K
Mehra Anand
Director · Restricted Stock Units · 2026-06-05
Exercise11.58K

SEC filings

EDGAR filings in ACRS · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.